Beam Therapeutics, Inc. (BEAM)
26.71
-0.73
(-2.66%)
USD |
NASDAQ |
Mar 05, 10:19
Beam Therapeutics Cash from Investing (TTM) : -121.44M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Twist Bioscience Corp. | -33.16M |
| Pacific Biosciences of California, Inc. | 115.45M |
| Intellia Therapeutics, Inc. | 228.03M |
| Stryker Corp. | -4.866B |
| Zimmer Biomet Holdings, Inc. | -1.976B |